Shenzhen Neptunus Bioengineering Co., Ltd. (SHE:000078)
China
· Delayed Price · Currency is CNY 3.320
+0.010 (0.30%)
Mar 10, 2026, 12:54 PM CST
SHE:000078 Revenue
Shenzhen Neptunus Bioengineering had revenue of 7.20B CNY in the quarter ending September 30, 2025, a decrease of -9.09%. This brings the company's revenue in the last twelve months to 27.28B, down -15.63% year-over-year. In the year 2024, Shenzhen Neptunus Bioengineering had annual revenue of 30.32B, down -16.75%.
Revenue (ttm)
27.28B
Revenue Growth
-15.63%
P/S Ratio
0.32
Revenue / Employee
3.30M
Employees
8,264
Market Cap
8.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30.32B | -6.10B | -16.75% |
| Dec 31, 2023 | 36.42B | -1.42B | -3.74% |
| Jan 1, 2023 | 37.83B | -3.22B | -7.84% |
| Jan 1, 2022 | 41.05B | 1.03B | 2.58% |
| Dec 31, 2020 | 40.02B | -1.47B | -3.54% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harbin Pharmaceutical Group | 15.94B |
| Tianjin Ringpu Bio-Technology | 3.37B |
| PharmaBlock Sciences (Nanjing) | 1.98B |
| Zhejiang Garden Biopharmaceutical | 1.24B |
| Zhejiang Xianju Pharmaceutical | 3.59B |
| KPC Pharmaceuticals,Inc. | 6.58B |
| Shandong Lukang Pharmaceutical | 6.19B |
| Chongqing Taiji Industry(Group) Co.,Ltd | 10.04B |